Summary & Overview
CPT 43239: Esophagogastroduodenoscopy with Biopsy
CPT code 43239 is a widely utilized billing code in gastroenterology, representing esophagogastroduodenoscopy (EGD) with biopsy, performed using a flexible, transoral endoscope. This procedure is critical for diagnosing and managing various gastrointestinal disorders, including malignancies and infections. Nationally, the code is recognized by major payers such as Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare, ensuring broad coverage across commercial and government insurance plans.
This publication provides a comprehensive overview of CPT code 43239, including its clinical context, typical sites of service, and payer coverage. Readers will gain insight into the procedural benchmarks, relevant policy updates, and the importance of this code in routine gastroenterology practice. The analysis also highlights common billing practices, such as the use of modifier 59 when reporting multiple endoscopic procedures on the same date of service. Additionally, associated diagnoses and related CPT codes are discussed to offer a complete picture of how 43239 fits within the broader landscape of endoscopic services.
Healthcare professionals, administrators, and policy analysts will find this summary valuable for understanding the national significance of CPT code 43239, its role in clinical care, and its impact on medical billing and reimbursement.
CPT Code Overview
CPT code 43239 describes an esophagogastroduodenoscopy (EGD) procedure performed with a flexible, transoral endoscope, including a biopsy of the esophagus, stomach, or duodenum. This service is commonly provided within the field of gastroenterology and is typically performed in an endoscopy suite or hospital outpatient setting (often place of service 22 or 11). The procedure allows for direct visualization and tissue sampling, which is essential for diagnosing a range of gastrointestinal conditions.
Clinical & Coding Specifications
Clinical Context
A patient presents with symptoms such as difficulty swallowing, unexplained weight loss, or persistent heartburn. The gastroenterologist decides to perform an esophagogastroduodenoscopy (EGD) using a flexible, transoral endoscope to visually examine the esophagus, stomach, and duodenum. During the procedure, biopsies are taken from suspicious areas to evaluate for conditions such as malignant neoplasm of the esophagus or candidal esophagitis. The procedure is typically performed in an endoscopy suite or hospital outpatient setting.
Coding Specifications
- Modifier
59: Distinct Procedural Service. Used when43239is reported with another endoscopy code, such as43249, on the same date of service to indicate that the procedures are separate and distinct.
| Modifier Code | Description | When Used |
|---|---|---|
59 | Distinct Procedural Service | When 43239 and another endoscopy code (e.g., 43249) are performed on the same day |
- Provider Taxonomies:
| Taxonomy Code | Specialty |
|---|---|
207RG0100X | Gastroenterology |
Related Diagnoses
-
C15.9: Malignant neoplasm of esophagus, unspecified- This diagnosis is relevant when the EGD with biopsy is performed to evaluate for or confirm esophageal cancer.
-
B37.81: Candidal esophagitis- This diagnosis is relevant when the EGD with biopsy is performed to assess for fungal infection of the esophagus, often in immunocompromised patients.
Related CPT Codes
43249: Esophagogastroduodenoscopy, flexible, transoral; with transendoscopic balloon dilation of esophagus (less than 30 mm diameter)
43249 is related to 43239 as both are endoscopic procedures performed via flexible, transoral approach. 43249 involves balloon dilation of the esophagus, which may be performed in conjunction with biopsy (43239) when both diagnostic and therapeutic interventions are needed. These codes are commonly used together when a patient requires both biopsy and dilation during the same session.
National Reimbursement Benchmarks
Medicare's national mean rate for CPT code 43239 is $435.75, closely aligned with Cigna at $434.44 and notably higher than the BUCA (Blue Cross Blue Shield, UnitedHealth Group, Cigna, Aetna) average commercial mean rate, which ranges from $267.23 (Aetna) up to $517.62 (UnitedHealth Group). The BUCA mean rate, calculated as the average of the commercial payers, is $361.31, which is lower than Medicare.
Rate dispersion varies significantly across payers. Aetna exhibits the tightest range between the 25th and 75th percentiles ($132.31), while UnitedHealth Group shows the widest spread ($268.00). This indicates that UnitedHealth Group's rates are more variable nationally, whereas Aetna's rates are more consistent.
The table and chart below present the full breakdown of national benchmarks for CPT code 43239 by payer, including mean rates and percentile values.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.